Thyme Care has established Thyme Care Oncology Partners, a dedicated platform for oncology practices.
We were thrilled to get “the call” from First Lady Jill Biden’s staff.
Thyme Care creates Thyme Care Oncology Partners, with over 400 oncologists nationwide
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
The process of navigating the cancer care continuum can be extremely complex, confusing, and frustrating for patients and caregivers. To achieve better outcomes, patients need to not only be aware of their options, but also have a comprehensive understanding of them and be able to act accordingly and with purpose.
Medicare has started to pay for navigation for guiding patients through the maze of health care services in settings where treatment involves multiple specialties.
As 2024 approaches, it’s anyone’s guess whether an already complex health care ecosystem gets to turn the corner on the mixed legacies of 2023—including record high prices on new blockbuster medications coupled with drug shortages on existing generics, persistent staff shortages and battered hospital margins, and a continued emphasis on value-based care programs by insurers.
The Advanced Research Projects Agency for Health will issue $240 million in cancer-related awards over the next few weeks, the White House announced at a Cancer Cabinet meeting Sept. 13.
Thyme Care raised $60 million in series B funding, co-led by Town Hall Ventures and Foresite Capital and with participation from current investors Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital, and Frist Cressey Ventures. The capital brings Thyme Care’s total capital raised to over $80 million (The Cancer Letter, Oct. 7, 2022).
